Ind-Swift Laboratories Limited is an Indian company that specializes in the development, manufacturing, and sale of active pharmaceutical ingredients (APIs). With a wide range of therapeutic areas covered, including cardiovascular, antidiabetic, antipsychotic, and more, the company offers APIs that cater to various medical needs. In addition to APIs, Ind-Swift Laboratories Limited also provides reference standards and impurities for specific pharmaceutical products. The company offers a comprehensive range of services, including early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis. With a strong focus on analytical development, regulatory support, and project management, Ind-Swift Laboratories Limited ensures the highest quality standards for its products. Founded in 1995 and headquartered in Manimajra, India, the company also exports its products to international markets.
Ind-Swift Laboratories Limited
- 0.00 0.00(0.00%) 115.05 4.45(4.02%)
Live Ind-Swift Laboratories Limited Share Price Chart
Ind-Swift Laboratories Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 111.90 | 116.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 86.20 (03-Dec-2024) 87.00 (03-Dec-2024) | 186.00 (02-Aug-2024) 186.00 (02-Aug-2024) |
- Open
- 111.90
- Previous Close
- 115.20 110.60
- Volume
- 0.00
- Total Traded value
- 0.00 (Lakhs)
- Upper circuit
- 120.96 127.95
- Lower circuit
- 109.44 85.35
Ind-Swift Laboratories Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 1,103 | 430 |
| Bid Price | Quantity |
|---|---|
| 115.20 | 100.00 |
| 111.50 | 1.00 |
| 111.25 | 100.00 |
| 111.21 | 200.00 |
| 0.00 | 0.00 |
| Total: | 1,103 |
| Ask Price | Quantity |
|---|---|
| 120.94 | 100.00 |
| 120.96 | 330.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 430 |
Ind-Swift Laboratories Limited Share Fundamentals
| Market Cap: | 630.16 Cr |
| PE Ratio (TTM): | 1.73 |
| PB Ratio: | 0.65 |
| Industry P/E: | 27.66 |
| Debt to Equity: | - |
| ROE: | 37.49 |
| EPS (TTM): | 63.93 |
| Book Value: | 121.90 |
| Face Value: | 10.00 |
Ind-Swift Laboratories Limited Stock Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 270.30 Cr | 299.01 Cr | 290.48 Cr | 302.41 Cr | 287.55 Cr |
| Profit | 30.10 Cr | 17.05 Cr | -30.91 Cr | 29.22 Cr | 24.02 Cr |
| Expense | 241.23 Cr | 273.46 Cr | 265.25 Cr | 284.30 Cr | 271.07 Cr |
| Comprehensive income | 29.72 Cr | 17.05 Cr | -30.59 Cr | 29.22 Cr | 24.02 Cr |
| EPS | 5.09 | 2.89 | -5.23 | 4.95 | 4.07 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Ind-Swift Laboratories Limited | Sep, 2000 Mar, 2000 | Pharmaceuticals Pharmaceuticals | INDSWFTLAB INDSWFTLAB |
Ind-Swift Laboratories Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Ind-Swift Laboratories Limited Share FAQ's
What is the range of today's stock performance for Ind-Swift Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 0.00 on the NSE (National Stock Exchange) to a maximum of 0.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 111.90 to a high of 116.00.
What are the 52-week low and high values for Ind-Swift Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 86.20 (occurred on 03-Dec-2024) and a high of 186.00 (achieved on 02-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 87.00 (on 03-Dec-2024), and the 52-week high is 186.00 (on 02-Aug-2024).
What was the opening and previous closing prices for Ind-Swift Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 86.20 (occurred on 03-Dec-2024) and a high of 186.00 (achieved on 02-Aug-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 87.00 (on 03-Dec-2024), and the 52-week high is 186.00 (on 02-Aug-2024).
What are the upper and lower circuit limits for Ind-Swift Laboratories Limited?
The upper circuit limit is 120.96, and the lower circuit limit is 109.44.
What is the PB ratio, industry P/E, and debt to equity ratio for Ind-Swift Laboratories Limited?
The PB ratio is 0.00, industry P/E is 27.66 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Ind-Swift Laboratories Limited?
ROE is 37.49, EPS is 63.93, book value is 121.90
What are the revenue and profit figures for the latest quarter and previous quarters for Ind-Swift Laboratories Limited?
In Sep 2023, Revenue is 2702999000.00, and Profit is 300955000.00. In Jun 2023, Revenue is 2990057000.00, and Profit is 170501000.00.
When was Ind-Swift Laboratories Limited listed, and what industry does it belong to?
The company, Ind-Swift Laboratories Limited, was listed in Sep 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is INDSWFTLAB.
What is the current shareholding pattern of the Ind-Swift Laboratories Limited?
As of latest available update, promoters hold 42.00%, the public holds 58.00%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 36
- Threads
- 195
